Nurix Therapeutics NRIX

$ 19.84 -1.0%

Quarterly report 2024-Q3
added 10-11-2024

Nurix Therapeutics Income Statement 2011-2024 | NRIX

Annual Income Statement Nurix Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	538 M	548 M	1.24 B	1.11 B	-	-	-	-	-	-	-	-	-
Shares	54.3 M	48.6 M	42.9 M	31.4 M	-	-	-	-	-	-	-	-	-
Historical Prices	9.9	11.3	28.9	32.9	-	-	-	-	-	-	-	-	-
Net Income	-144 M	-180 M	-117 M	-43.2 M	-21.7 M	-9.43 M	-	-	-	-	-	-	-
Revenue	77 M	38.6 M	29.8 M	17.8 M	31.1 M	37.4 M	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	17.8 M	-	-	-	-	-	-	-	-	-
Operating Income	-155 M	-184 M	-118 M	-65 M	-22.2 M	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-148 M	-179 M	-115 M	-62.8 M	-19.9 M	-6.75 M	-	-	-	-	-	-	-
Operating Expenses	232 M	222 M	148 M	82.8 M	53.4 M	47.2 M	-	-	-	-	-	-	-
General and Administrative Expenses	42.9 M	38 M	31.2 M	16.3 M	8.33 M	6.67 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Nurix Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	72.8 M	62.4 M	54.9 M	48.7 M	54.4 M	54.3 M	54 M	47.2 M	50.9 M	44.9 M	44.7 M	44.7 M	44.4 M	43.8 M	38.8 M	38.7 M	16.9 M	3.73 M	3.54 M	3.81 M	3.67 M	3.43 M	3.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-49 M	-44.5 M	-41.5 M	-	-37 M	-24.3 M	-40.7 M	-	-45.7 M	-45.4 M	-42.5 M	-	-28.8 M	-26.4 M	-24.3 M	-19.9 M	-18.5 M	7.58 M	-12.4 M	-13.5 M	-2.43 M	-3.07 M	-2.68 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	12.6 M	12.1 M	16.6 M	-	18.5 M	30.7 M	12.7 M	-	10.8 M	11.4 M	9.62 M	-	10.3 M	7.09 M	5.01 M	6.69 M	4.08 M	4.18 M	2.86 M	1.86 M	10.6 M	9.44 M	9.23 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-54.6 M	-48.5 M	-45.2 M	-	-40 M	-26.8 M	-43 M	-	-46.7 M	-45.7 M	-42.7 M	-	-29 M	-26.4 M	-24.5 M	-	-19.2 M	-13.2 M	-12.6 M	-	-2.61 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-43.2 M	-	-	-	-41.2 M	-	-45.2 M	-44.4 M	-41.8 M	-	-28.3 M	-25.8 M	-23.9 M	-	-18.6 M	-12.7 M	-12.1 M	-	-2.01 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	67.2 M	60.6 M	61.8 M	-	58.5 M	57.4 M	55.6 M	-	57.5 M	57.1 M	52.4 M	-	39.2 M	33.5 M	29.5 M	-	23.3 M	17.4 M	15.4 M	-	13.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	11.7 M	11.7 M	11.8 M	-	10.6 M	11.7 M	9.82 M	-	9.75 M	9.65 M	9.23 M	-	8.34 M	7.51 M	6.53 M	-	4.34 M	3.27 M	2.45 M	-	2.18 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency